Liquidia Corp (LQDA)
12.98
-0.19
(-1.44%)
USD |
NASDAQ |
May 02, 16:00
12.98
0.00 (0.00%)
After-Hours: 16:18
Liquidia 1 Year Total Returns (Daily): 97.16% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | 97.16% |
| April 30, 2024 | 91.51% |
| April 29, 2024 | 85.77% |
| April 26, 2024 | 85.36% |
| April 25, 2024 | 84.63% |
| April 24, 2024 | 84.56% |
| April 23, 2024 | 86.60% |
| April 22, 2024 | 89.91% |
| April 19, 2024 | 89.86% |
| April 18, 2024 | 97.85% |
| April 17, 2024 | 97.72% |
| April 16, 2024 | 100.9% |
| April 15, 2024 | 102.4% |
| April 12, 2024 | 109.1% |
| April 11, 2024 | 127.4% |
| April 10, 2024 | 120.0% |
| April 09, 2024 | 121.6% |
| April 08, 2024 | 124.1% |
| April 05, 2024 | 133.4% |
| April 04, 2024 | 120.8% |
| April 03, 2024 | 118.0% |
| April 02, 2024 | 122.6% |
| April 01, 2024 | 115.9% |
| March 28, 2024 | 116.9% |
| March 27, 2024 | 119.4% |
| Date | Value |
|---|---|
| March 26, 2024 | 132.4% |
| March 25, 2024 | 128.8% |
| March 22, 2024 | 143.9% |
| March 21, 2024 | 125.6% |
| March 20, 2024 | 123.9% |
| March 19, 2024 | 122.0% |
| March 18, 2024 | 115.5% |
| March 15, 2024 | 150.0% |
| March 14, 2024 | 135.0% |
| March 13, 2024 | 127.0% |
| March 12, 2024 | 126.9% |
| March 11, 2024 | 120.9% |
| March 08, 2024 | 100.0% |
| March 07, 2024 | 94.31% |
| March 06, 2024 | 86.71% |
| March 05, 2024 | 87.87% |
| March 04, 2024 | 86.51% |
| March 01, 2024 | 95.42% |
| February 29, 2024 | 87.05% |
| February 28, 2024 | 90.03% |
| February 27, 2024 | 94.31% |
| February 26, 2024 | 95.45% |
| February 23, 2024 | 87.68% |
| February 22, 2024 | 87.70% |
| February 21, 2024 | 91.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.70%
Minimum
Oct 09 2019
215.4%
Maximum
Aug 15 2022
14.40%
Average
10.13%
Median
1 Year Total Returns (Daily) Benchmarks
| United Therapeutics Corp | 9.87% |
| AIM ImmunoTech Inc | -15.22% |
| Perspective Therapeutics Inc | 176.8% |
| Protalix BioTherapeutics Inc | -58.28% |
| Armata Pharmaceuticals Inc | 54.84% |